Systemic estradiol levels with low-dose vaginal estrogens

Area of Science:

• Endocrinology
• Gynecology
• Pharmacology

Background:

• Vaginal estrogen therapy is used for genitourinary syndrome of menopause.
• Accurate measurement of systemic estradiol levels is crucial for assessing safety and efficacy.
• Low-dose formulations aim to minimize systemic absorption and associated risks.

Purpose of the Study:

• To evaluate systemic estradiol levels with low-dose vaginal estrogens.
• To compare levels based on detection method and estrogen dose.
• To determine normal estradiol ranges in postmenopausal women.

Main Methods:

• Systematic literature search of PubMed for relevant studies.
• Summarized estradiol levels (baseline, treatment, AUC, Cmax) by dose and assay type.
• Estimated normal postmenopausal estradiol range using pooled data.

Main Results:

• Estradiol levels varied significantly by assay: LC/GC-MS/MS yielded lower results than radioimmunoassay.
• Systemic estradiol absorption was dose-dependent and influenced by formulation and vaginal placement.
• Proposed normal postmenopausal basal estradiol range: undetectable to 10.7 pg/mL.

Conclusions:

• More sensitive assays show lower serum estradiol concentrations.
• Low systemic absorption of low-dose vaginal estrogens may reduce adverse event risk.
• Dose, formulation, and application site impact estradiol absorption.